Literature DB >> 19190656

Haemostatic markers are associated with measures of vascular disease in adults with hypertension.

M Khaleghi1, L A Singletary, V Kondragunta, K R Bailey, S T Turner, T H Mosley, I J Kullo.   

Abstract

Haemostatic markers have been implicated in the development and progression of vascular disease. We investigated the associations of several haemostatic markers (fibrinogen, D-dimer, FV, FVII, FVIII, von Willebrand factor (vWF) and antithrombin III) with two quantitative measures of vascular disease in adults with hypertension. Participants included 1051 African Americans (65+/-9 years, 72% women) and 894 non-Hispanic whites (61+/-9 years, 55% women) belonging to hypertensive sibships. Phenotypes of vascular disease included the ankle-brachial index (ABI), a measure of peripheral arterial disease, and urinary albumin/creatinine ratio (UACR), a surrogate of glomerular endothelial function. Generalized estimating equations were used to assess whether plasma levels of haemostatic markers were associated with measures of arteriosclerosis, after adjustment for conventional risk factors and medication (statin, aspirin and oestrogen) use. Higher fibrinogen and D-dimer were significantly associated with lower ABI in African Americans (P<0.001 and 0.004 respectively) and in non-Hispanic whites (P<0.001 and 0.010 respectively). Higher fibrinogen (P<0.001), D-dimer (P=0.003), FVIII (P<0.001) and vWF (P<0.001) were significantly associated with higher UACR in African Americans, whereas, in non-Hispanic whites, higher fibrinogen (P=0.020) and FVII (P=0.006) were significantly associated with higher UACR. Our findings indicate that in adults with essential hypertension, several markers in the haemostatic pathway are independently associated with ABI and UACR, two measures of vascular disease..

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190656      PMCID: PMC2712646          DOI: 10.1038/jhh.2008.170

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  33 in total

1.  Does hypertension confer a prothrombotic state? Virchow's triad revisited.

Authors:  G Y Lip; A D Blann
Journal:  Circulation       Date:  2000-01-25       Impact factor: 29.690

2.  Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP).

Authors: 
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

Review 3.  Medical treatment of peripheral arterial disease and claudication.

Authors:  W R Hiatt
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

4.  The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Matthew A Allison; Michael H Criqui; Robyn L McClelland; JoAnn M Scott; Mary M McDermott; Kiang Liu; Aaron R Folsom; Alain G Bertoni; A Richey Sharrett; Shunichi Homma; Sujata Kori
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

5.  Association of blood pressure with fibrinolytic potential in the Framingham offspring population.

Authors:  K A Poli; G H Tofler; M G Larson; J C Evans; P A Sutherland; I Lipinska; M A Mittleman; J E Muller; R B D'Agostino; P W Wilson; D Levy
Journal:  Circulation       Date:  2000-01-25       Impact factor: 29.690

6.  Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension.

Authors:  L A Sechi; L Zingaro; C Catena; D Casaccio; S De Marchi
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

7.  Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.

Authors:  Ioanna Tzoulaki; Gordon D Murray; Jacqueline F Price; Felicity B Smith; Amanda J Lee; Ann Rumley; Gordon D O Lowe; F Gerald R Fowkes
Journal:  Am J Epidemiol       Date:  2005-12-15       Impact factor: 4.897

Review 8.  von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.

Authors:  Alexander O Spiel; James C Gilbert; Bernd Jilma
Journal:  Circulation       Date:  2008-03-18       Impact factor: 29.690

9.  Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort.

Authors:  Laura M Reich; Gerardo Heiss; Lori L Boland; Alan T Hirsch; Kenneth Wu; Aaron R Folsom
Journal:  Vasc Med       Date:  2007-11       Impact factor: 3.239

10.  Enhancement of interleukin-6 production by fibrinogen degradation product D in human peripheral monocytes and perfused murine liver.

Authors:  J Mandl; M Csala; I Léránt; G Bánhegyi; J Biró; R Machovich; A Falus
Journal:  Scand J Immunol       Date:  1995-07       Impact factor: 3.487

View more
  8 in total

1.  Modeling the Causal Role of DNA Methylation in the Association Between Cigarette Smoking and Inflammation in African Americans: A 2-Step Epigenetic Mendelian Randomization Study.

Authors:  Min A Jhun; Jennifer A Smith; Erin B Ware; Sharon L R Kardia; Thomas H Mosley; Stephen T Turner; Patricia A Peyser; Sung Kyun Park
Journal:  Am J Epidemiol       Date:  2017-11-15       Impact factor: 4.897

2.  Central aortic pulse pressure, thrombogenicity and cardiovascular risk.

Authors:  Gailing Chen; Kevin P Bliden; Rahul Chaudhary; Fang Liu; Himabindu Kaza; Eliano P Navarese; Udaya S Tantry; Paul A Gurbel
Journal:  J Thromb Thrombolysis       Date:  2017-08       Impact factor: 2.300

3.  Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease.

Authors:  Zi Ye; Zeenat Ali; George G Klee; Thomas H Mosley; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2013-01-11       Impact factor: 2.689

4.  Endothelial cell markers in patients with pseudoexfoliation syndrome.

Authors:  Joanna Stafiej; Grażyna Malukiewicz; Hanna Lesiewska-Junk; Danuta Rość; Karolina Kaźmierczak
Journal:  ScientificWorldJournal       Date:  2012-04-19

5.  Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity.

Authors:  Xia Yang; Hai-jian Sun; Zhi-rong Li; Hao Zhang; Wei-jun Yang; Bing Ni; Yu-zhang Wu
Journal:  BMC Cancer       Date:  2015-02-21       Impact factor: 4.430

6.  The Role of Early Revascularization and Biomarkers in the Management of Diabetic Foot Ulcers: A Single Center Experience.

Authors:  Ettore Dinoto; Francesca Ferlito; Manfredi Agostino La Marca; Graziella Tortomasi; Francesca Urso; Salvatore Evola; Giovanni Guercio; Marco Marcianò; David Pakeliani; Guido Bajardi; Felice Pecoraro
Journal:  Diagnostics (Basel)       Date:  2022-02-19

7.  Cadmium regulates von Willebrand factor and occludin expression in glomerular endothelial cells of mice in a TNF-α-dependent manner.

Authors:  Zongguo Sun; Qi Xie; Jie Pan; Na Niu
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

8.  Dihydroartemisinin inhibits the expression of von Willebrand factor by downregulation of transcription factor ERG in endothelial cells.

Authors:  Fengyun Dong; Xinghai Zhao; Jianning Wang; Xin Huang; Xiao Li; Liang Zhang; Haixin Dong; Fuhong Liu; Mengge Fan
Journal:  Fundam Clin Pharmacol       Date:  2020-11-07       Impact factor: 2.748

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.